logo

ORIC

ORIC PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ORIC Profile

Oric Pharmaceuticals, Inc.

A clinical stage biopharmaceutical company that develops commercializes novel therapies to address the resistance in cancer

Biological Technology
--
04/24/2020
NASDAQ Stock Exchange
115
12-31
Common stock
240 E. Grand Ave, 2nd Floor, South San Francisco, CA 94080
--
ORIC Pharmaceuticals, Inc., was incorporated in Delaware in August 2014. The company is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients by overcoming cancer resistance.